Latest Commercialization News

Carnaby Resources has reported a standout drill result of 18 metres at 5.0% copper equivalent at its Trek 2 prospect, signalling significant growth potential beyond current resource estimates at the Greater Duchess Copper Gold Project.

Victory Metals has reported a breakthrough flotation test achieving a 48-fold upgrade in rare earth concentration at its North Stanmore project, setting the stage for a lower-cost, faster path to market.

Conrad Asia Energy has formally approved the Final Investment Decision for its Mako Gas Project in Indonesia, securing full funding and long-term sales contracts, with first gas expected in late 2027.

Bio-Gene Technology Limited reports strong progress in toxicology studies for Flavocide, targeting its first regulatory submission in Australia by March 2027. This milestone sets the stage for global registrations of the novel insecticide with a new mode of action.

Orezone Gold Corporation reported a robust 33% revenue increase for FY2025, driven by higher gold prices despite a slight production dip, while advancing its Bomboré hard rock expansion and announcing a major Quebec mine acquisition.

Terragen Holdings’ biostimulant Great Land Plus® has been independently shown to increase maize silage yields by up to 12%, translating into an estimated $1,100 additional revenue per hectare and a potential 20-fold return on investment.

Omega Oil and Gas has locked in Helmerich & Payne’s FlexRig® 648 to power an expanded 2026/27 drilling campaign in Queensland’s Taroom Trough, aiming to unlock a vast unconventional oil and gas resource.

Yari Minerals has validated the high quality of coal at its Rolleston South project, revealing low ash and sulphur levels that promise strong market appeal and underpin a substantial resource base.

Chimeric Therapeutics has secured a $1.785 million advance against its anticipated FY26 Research and Development Tax Incentive to bolster its clinical trial pipeline and working capital.

ABx Group’s maiden mixed rare earth carbonate from Tasmania’s Deep Leads resource has been confirmed radiologically safe by ANSTO, with a second, higher-grade sample expected soon. The development could open doors to key international customers and reduce regulatory complexities.

Metal Powder Works has partnered with CenterLine to develop Kirksite alloy powders for cold spray automotive tooling, targeting a USD 100-300 million market. This collaboration aims to enhance tooling repair speed and cost-efficiency in the automotive sector.

Avecho Biotechnology has completed recruitment for the interim analysis cohort of its pivotal Phase III trial for a CBD insomnia treatment, with results expected in June 2026. This milestone could significantly de-risk the program and unlock major market opportunities.